A Randomized, Double-Blind, Active-Controlled, Subject Initiated Study Comparing ME-609 to Acyclovir Cream for Treatment of Recurrent Herpes Simplex Labialis in Immunocompromised Patients

Trial Profile

A Randomized, Double-Blind, Active-Controlled, Subject Initiated Study Comparing ME-609 to Acyclovir Cream for Treatment of Recurrent Herpes Simplex Labialis in Immunocompromised Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Dec 2012

At a glance

  • Drugs Aciclovir/hydrocortisone (Primary) ; Aciclovir
  • Indications Herpes labialis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Dec 2010 Results presented at the 45th American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition, according to a Medivir media release.
    • 01 Oct 2008 Medivir submitted NDA to the US FDA, according to media release.
    • 08 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top